Skip to main content

OKYO Pharma Ltd ADR (OKYO) Stock

OKYO Pharma Ltd ADR Stock Details, Movements and Public Alerts

Stock Details

OKYO Pharma Ltd ADR (OKYO), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $2.01. Over the past 52 weeks, it has ranged between $0.90 and $3.35. This places the current price at 60.0% of its 52-week high and 122.8% above its 52-week low. Recent trading volume was recorded at 31,332. The 14-day Relative Strength Index (RSI) stands at 52.30, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $2.22 by 9.46%. Similarly, it is below its 200-day moving average of $2.06 by 2.43%. The MACD histogram is 0.02, indicating bullish momentum (MACD Line: -0.09, Signal Line: -0.11). There is currently 1 active alert set for OKYO by users.

52-Week Range

$3.35 - $0.90

-39.98% from high · +122.84% from low

Avg Daily Volume

180,979

20-day average

100-day avg: 145,437

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

14.11

EV/EBITDA

-4.29

EPS (TTM)

-$0.12

Beta

-0.18

Less volatile than market

How is OKYO valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is OKYO's risk profile compared to the market?
With a beta of -0.18, OKYO Pharma Ltd ADR is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 14.11 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-7,089,334

Return on Equity

-2969.00%

Return on Assets

-169.90%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is OKYO's business model?
Profitability metrics are not available for this stock.
What are OKYO's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$89.9M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

37.61M

Book Value/Share

-$0.15

Asset Type

Common Stock

What is OKYO's market capitalization and position?
OKYO Pharma Ltd ADR has a market capitalization of $89.9M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 37.61M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does OKYO's price compare to its book value?
OKYO Pharma Ltd ADR's book value per share is -$0.15, while the current stock price is $2.01, resulting in a price-to-book (P/B) ratio of -13.05. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$10.00

397.51% upside potential

Analyst Recommendations

No analyst ratings available

How reliable are analyst predictions for OKYO?
0 analysts cover OKYO with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $10.00 implies 397.5% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on OKYO?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 1, 2025, 02:08 AM

Technical Indicators

RSI (14-day)

52.30

Neutral

50-Day Moving Average

$2.22

-9.46% below MA-50

200-Day Moving Average

$2.06

-2.43% below MA-200

MACD Line

-0.09

MACD Signal

-0.11

MACD Histogram

0.02

Bullish

What does OKYO's RSI value tell investors?
The RSI (Relative Strength Index) for OKYO is currently 52.30, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
How should traders interpret OKYO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.09 above the signal line at -0.11, with histogram at 0.02. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($2.22) is above the 200-day MA ($2.06), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently below both MAs, confirming weakness.

Indicators last updated: Dec 12, 2025, 12:45 AM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Dec 4, 2025, 04:18 PM

Stay Ahead of the Market with OKYO Pharma Ltd ADR Alerts

Set up price alerts for OKYO Pharma Ltd ADR and get notified instantly when the price hits your target. Never miss an important price movement again.